Who Owns MNPR?

Monopar Therapeutics Inc. — Institutional Ownership & 13F Holdings

$54.10

+0.08 (+0.15%)

Market Cap

$356.0M

Shares Outstanding

6,692,140

Institutional Holders

35

Total Inst. Value

$42.7M

% of Float Held

65.6%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ADAGE CAPITAL PARTNERS GP, L.L.C.$21.8M599,195
2Point72 Asset Management, L.P.$6.1M168,160
3ADAR1 Capital Management, LLC$3.7M100,774
4Affinity Asset Advisors, LLC$2.3M62,000
5VANGUARD GROUP INC$2.0M55,234
6GEODE CAPITAL MANAGEMENT, LLC$1.8M48,540
7MARSHALL WACE, LLP$946K25,988
8GOLDMAN SACHS GROUP INC$673K18,480
9STATE STREET CORP$575K15,814
10BlackRock, Inc.$527K14,464

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold MNPR?

As of Q1 2025, 35 institutional investors report holding MNPR (Monopar Therapeutics Inc.) in their 13F filings.

What percentage of Monopar Therapeutics Inc. is owned by institutions?

Institutional investors hold approximately 65.6% of Monopar Therapeutics Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most MNPR?

The largest institutional holder of MNPR is ADAGE CAPITAL PARTNERS GP, L.L.C. with $21.8M in shares.

Are institutions buying or selling MNPR?

This quarter, 18 institutions opened new positions in MNPR and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.